Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2021-08-17 00:00:00 ET · period of report 2021-08-13 · accession 0001209191-21-052085 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-17 | 2021-08-13 | TVTX | Heerma Peter | Chief Commercial Off | A - Grant | $0.00 | +4,500 | 64.9K | +7% | $0 | |
| 2021-08-17 | 2021-08-17 | TVTX | Heerma Peter | Chief Commercial Off | S - Sale | $17.12 | -1,407 | 63.5K | -2% | -$24.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-13 | A | A | 4,500 | $0.00 | 64,922 | D | — | — | (F2) Includes 1,078 shares of the Issuer's common stock acquired by the reporting person on May 31, 2021 pursuant to an employee stock purchase program. |
| 2 | Common | Common Stock | 2021-08-17 | S | D | 1,407 | $17.12 | 63,515 | D | — | — |